AdvisorShares Psychedelics ETF (PSIL)

Assets	$31.47M
Expense Ratio	1.00%
PE Ratio	n/a
Shares Out	1.57M
Dividend (ttm)	$1.72
Dividend Yield	8.68%
Ex-Dividend Date	Dec 22, 2025
Payout Frequency	n/a
Payout Ratio	n/a

Volume	14,326
Open	19.60
Previous Close	19.63
Day's Range	19.51 - 19.86
52-Week Low	11.10
52-Week High	22.49
Beta	0.90
Holdings	32
Inception Date	Sep 15, 2021

About PSIL

Fund Home Page

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is issued by AdvisorShares.

• Asset Class: Equity
• Category: Miscellaneous Sector
• Stock Exchange: NYSEARCA
• Ticker Symbol: PSIL
• ETF Provider: AdvisorShares

Top 10 Holdings

68.26% of assets

Name	Symbol	Weight
AtaiBeckley Inc.	ATAI	11.08%
COMPASS Pathways plc	CMPS	9.97%
Relmada Therapeutics, Inc.	RLMD	8.68%
Definium Therapeutics, Inc.	DFTX	8.66%
GH Research PLC	GHRS	5.58%
NRx Pharmaceuticals, Inc.	NRXP	5.46%
Bright Minds Biosciences Inc.	DRUG	5.08%
Cybin Inc.	HELP	4.63%
Neuronetics, Inc.	STIM	4.56%
Alto Neuroscience, Inc.	ANRO	4.56%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 22, 2025	$1.6839	Dec 29, 2025
Sep 22, 2025	$0.0201	Sep 29, 2025
Jun 23, 2025	$0.01191	Jun 27, 2025
Mar 21, 2025	$0.16343	Mar 28, 2025
Dec 23, 2024	$0.0548	Dec 30, 2024
Sep 23, 2024	$0.1087	Sep 30, 2024

Performance

PSIL had a total return of 85.12% in the past year, including dividends. Since the fund's inception, the average annual return has been -27.51%.